Latest Singapore News

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

Austco Healthcare’s subsidiary has locked in a decade-long maintenance contract at Jurong Health Complex, reinforcing its strategy to boost recurring revenue through long-term service agreements.

OFX Group has accepted a recommended all-cash takeover bid from UK-based Equals at $1.00 per share, more than doubling its share price from early February. The deal values OFX at $247 million equity and hinges on due diligence, debt financing, and shareholder approval, while the company reports steady growth in its corporate payments business and strong non-FX revenue.

Nanoveu’s ECS-DoT edge-AI chip has proven its mettle in live drone trials with up to 51% energy efficiency gains, while the acquisition of Spinoff Robotics adds proprietary drone platforms and engineering talent to accelerate commercialisation.

IDT Australia boosts its FY26 revenue guidance to $16.8 million, anticipating a substantial narrowing of EBITDA losses to under $1 million, driven by strong demand and cost efficiencies.

Activeport signs GOIP Globalnet to its Global Edge network, marking the third international carrier deal in a week and reinforcing its strategy for recurring revenue growth.

Toubani Resources (ASX: TRE) has launched the retail tranche of its fully underwritten A$70 million entitlement offer at A$0.30 per share, following a successful institutional raise, to fund the Kobada Gold Mine’s construction and exploration.

Activeport’s Global Edge platform has secured contracts with Spark and ViewQwest, setting the stage for a significant uplift in recurring revenue and international expansion.

Steadfast Group confirms Kohlberg Kravis Roberts has joined the consortium bidding to acquire the company at $6 per share, with no change to the transaction timeline or terms.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.

Pacific Edge edges closer to Medicare reimbursement for its bladder cancer tests while its Asia Pacific operations show rising test volumes and improved margins, signaling a path toward profitability.

Norwest Minerals is raising $1.89 million through a partly underwritten 1-for-4 entitlement offer priced at $0.007 per share to fund key stages of its Bulgera Heap Leach Scoping Study and secure solvency for FY2026. The offer is supported by director and major shareholder commitments and opens to eligible shareholders on 21 July 2026.